Literature DB >> 12424628

Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism.

T C T M van der Pouw Kraan1, M Küçükaycan, A M Bakker, J M C Baggen, J S van der Zee, M A Dentener, E F M Wouters, C L Verweij.   

Abstract

IL-13 is strongly implicated in the development of asthma and chronic obstructive pulmonary disease (COPD). We previously identified an IL-13 promoter polymorphism (-1055 C to T) that is associated with allergic asthma. We now report an increased frequency of the -1055 T allele in COPD patients compared to healthy controls (P=0.002) and compared to a second control group consisting of smoking individuals with normal lung function (P=0.01). A closely linked IL-13 exon polymorphism is present at normal allelic frequencies (P=0.3 and 0.4, respectively). In addition, we observed a normal distribution of two IL-4 polymorphisms at positions -590 and +33 (P=0.2 and 0.9, respectively). These results could implicate a functional role for the IL-13 promoter polymorphism in the enhanced risk to develop COPD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424628     DOI: 10.1038/sj.gene.6363896

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  32 in total

1.  ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo.

Authors:  Patty J Lee; Xuchen Zhang; Peiying Shan; Bing Ma; Chun Geun Lee; Robert J Homer; Zhou Zhu; Mercedes Rincon; Brooke T Mossman; Jack A Elias
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

2.  Evaluation of interleukin 13 polymorphisms in systemic sclerosis.

Authors:  Brigitte Granel; Christophe Chevillard; Yannick Allanore; Violaine Arnaud; Sandrine Cabantous; Sandrine Marquet; Pierre-Jean Weiller; Jean-Marc Durand; Jean-Robert Harlé; Claire Grange; Yves Frances; Philippe Berbis; Jean Gaudart; Philippe de Micco; André Kahan; Alain Dessein
Journal:  Immunogenetics       Date:  2006-07-11       Impact factor: 2.846

3.  Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer.

Authors:  Zahra Faghih; Nasrollah Erfani; Mahboobeh Razmkhah; Safoura Sameni; Abdolrasoul Talei; Abbas Ghaderi
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

4.  Lack of association between the G+2044A polymorphism of interleukin-13 gene and chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Lian Duan; Rui Liang; Zhendong Wang; Lei Lei; Lianhong Jin; Jingling Shen; Shoude Jin
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

Review 5.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

6.  Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.

Authors:  David M Habiel; Milena S Espindola; Ana L Coelho; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2018-02-17       Impact factor: 4.307

7.  Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease.

Authors:  Stefan Pabst; Vildan Yenice; Martina Lennarz; Izabela Tuleta; Georg Nickenig; Adrian Gillissen; Christian Grohé
Journal:  Lung       Date:  2009-04-19       Impact factor: 2.584

8.  Decreased expression of interleukin 13 in human lung emphysema.

Authors:  A Boutten; M Bonay; S Laribe; G Leseche; Y Castier; V Leçon-Malas; M Fournier; G Durand; M Aubier; M Dehoux; B Crestani
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 9.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.

Authors:  Jessica M Bon; Joseph K Leader; Joel L Weissfeld; Harvey O Coxson; Bin Zheng; Robert A Branch; Venkateswarlu Kondragunta; Janet S Lee; Yingze Zhang; Augustine M K Choi; Anna E Lokshin; Naftali Kaminski; David Gur; Frank C Sciurba
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.